ES2103952T3 - Sistemas terapeuticos transdermicos. - Google Patents

Sistemas terapeuticos transdermicos.

Info

Publication number
ES2103952T3
ES2103952T3 ES92914236T ES92914236T ES2103952T3 ES 2103952 T3 ES2103952 T3 ES 2103952T3 ES 92914236 T ES92914236 T ES 92914236T ES 92914236 T ES92914236 T ES 92914236T ES 2103952 T3 ES2103952 T3 ES 2103952T3
Authority
ES
Spain
Prior art keywords
therapeutic systems
transdermic
transdermic therapeutic
polar penetration
penetration intensifier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92914236T
Other languages
English (en)
Inventor
Jutta Riedl
Ralph Lipp
Matthias Hartisch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of ES2103952T3 publication Critical patent/ES2103952T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE DESCRIBEN SISTEMAS TERAPEUTICOS TRANSDERMALES CARACTERIZADOS PORQUE CONTIENEN UNA SUSTANCIA ACTIVA EN UNA MATRIZ ADHESIVA, UN INTENSIFICADOR DE PENETRACION POLAR Y UN INTENSIFICADOR DE PENETRACION NO POLAR QUE ES INSOLUBLE EN EL INTENSIFICADOR DE PENETRACION POLAR.
ES92914236T 1991-07-30 1992-07-07 Sistemas terapeuticos transdermicos. Expired - Lifetime ES2103952T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4125611 1991-07-30
DE4210165A DE4210165A1 (de) 1991-07-30 1992-03-25 Transdermale therapeutische systeme

Publications (1)

Publication Number Publication Date
ES2103952T3 true ES2103952T3 (es) 1997-10-01

Family

ID=25906037

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92914236T Expired - Lifetime ES2103952T3 (es) 1991-07-30 1992-07-07 Sistemas terapeuticos transdermicos.

Country Status (14)

Country Link
EP (1) EP0596903B1 (es)
JP (1) JPH06509346A (es)
AT (1) ATE151985T1 (es)
AU (1) AU676826B2 (es)
CA (1) CA2114537A1 (es)
DE (2) DE4210165A1 (es)
DK (1) DK0596903T3 (es)
ES (1) ES2103952T3 (es)
FI (1) FI940427A0 (es)
GR (1) GR3024097T3 (es)
HU (1) HU217215B (es)
NO (1) NO307736B1 (es)
PT (1) PT100737B (es)
WO (1) WO1993002669A1 (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993025168A1 (en) * 1992-06-11 1993-12-23 Theratech, Inc. The use of glycerin in moderating transdermal drug delivery
US5843979A (en) * 1993-02-25 1998-12-01 Bristol-Myers Squibb Company Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity
US5460820B1 (en) † 1993-08-03 1999-08-03 Theratech Inc Method for providing testosterone and optionally estrogen replacement therapy to women
DE4332094C2 (de) * 1993-09-22 1995-09-07 Lohmann Therapie Syst Lts Lösemittelfrei herstellbares Wirkstoffpflaster und Verfahren zu seiner Herstellung
DE4405899A1 (de) * 1994-02-18 1995-08-24 Schering Ag Mittel zur transdermalen Applikation enthaltend Desogestrel
DE4429667C2 (de) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
EP0742011B1 (en) * 1994-11-17 2002-07-24 Toray Industries, Inc. Percutaneously absorbable preparation
DE19526864A1 (de) * 1995-07-22 1997-01-23 Labtec Gmbh Hormonpflaster
DE19533089C1 (de) * 1995-09-07 1997-05-22 Hexal Ag Tacrin-Pflaster
DE19626621A1 (de) * 1996-07-02 1998-01-08 Hexal Ag Pflaster zur transdermalen Anwendung von Pergolid
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
EP0979072B1 (en) * 1997-02-28 2005-04-27 Minnesota Mining And Manufacturing Company Transdermal device for the delivery of testosterone
FR2761889B1 (fr) * 1997-04-11 1999-12-31 Oreal Patch pharmaceutique, cosmetique ou dermo-pharmaceutique pour la delivrance de plusieurs composes actifs de nature differente
US7011843B2 (en) 1997-10-01 2006-03-14 Lts Lohmann-Therapie Systeme Ag Method for protecting a human being against health impairment by ingestion of a transdermal therapeutic system
DE10019171A1 (de) * 2000-04-07 2001-10-18 Schering Ag Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe
DE10107663B4 (de) * 2001-02-19 2004-09-09 Lts Lohmann Therapie-Systeme Ag Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
AU2003279493B2 (en) 2002-10-25 2009-08-20 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
CN1856294A (zh) * 2003-08-25 2006-11-01 弗米克斯有限公司 渗透性药物泡沫
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
BRPI0816256A2 (pt) 2007-09-13 2015-03-17 Basf Se Uso de hidrofobina, e, processo para a preparação de um agente para a absorção melhorada de substâncias ativas no uso tópico
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
DE102008006791B4 (de) * 2008-01-30 2011-11-24 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System mit Harnstoff-Komponente und Verfahren zu dessen Herstellung
US20110207765A1 (en) * 2008-10-31 2011-08-25 Moberg Derma Ab Topical composition comprising a combination of at least two penetration enhancing agents
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
MX359879B (es) 2009-10-02 2018-10-12 Foamix Pharmaceuticals Ltd Composiciones tópicas de tetraciclina.
CA2978573A1 (en) 2016-09-08 2018-03-08 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5855411A (ja) * 1981-09-28 1983-04-01 Nitto Electric Ind Co Ltd 基剤組成物および外用医薬組成物
EP0224981A3 (en) * 1985-11-04 1988-08-10 Paco Research Corporation Nitroglycerin transdermal delivery system
EP0394429B1 (de) * 1988-10-27 1996-01-10 Schering Aktiengesellschaft Mittel zur transdermalen applikation enthaltend gestoden
ATE107517T1 (de) * 1989-05-25 1994-07-15 Takeda Chemical Industries Ltd Transdermales therapeutisches mittel.
HUT59596A (en) * 1989-08-17 1992-06-29 Schering Corp Process for producing transdermal nitroglicerol patches
AU6712090A (en) * 1989-10-13 1991-05-16 Watson Laboratories, Inc. Drug delivery systems and matrix therefor
AR246186A1 (es) * 1989-11-17 1994-07-29 Beta Pharm Co Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica.

Also Published As

Publication number Publication date
HUT66125A (en) 1994-09-28
HU217215B (hu) 1999-12-28
EP0596903A1 (de) 1994-05-18
JPH06509346A (ja) 1994-10-20
DE4210165A1 (de) 1993-02-04
NO307736B1 (no) 2000-05-22
PT100737B (pt) 1999-07-30
AU2229892A (en) 1993-03-02
FI940427L (fi) 1994-01-28
ATE151985T1 (de) 1997-05-15
AU676826B2 (en) 1997-03-27
FI940427A7 (fi) 1994-01-28
DK0596903T3 (da) 1997-11-03
NO940313D0 (no) 1994-01-28
FI940427A0 (fi) 1994-01-28
GR3024097T3 (en) 1997-10-31
PT100737A (pt) 1993-10-29
HU9400253D0 (en) 1994-05-30
DE59208408D1 (de) 1997-05-28
WO1993002669A1 (de) 1993-02-18
EP0596903B1 (de) 1997-04-23
NO940313L (no) 1994-01-28
CA2114537A1 (en) 1993-02-18

Similar Documents

Publication Publication Date Title
ES2103952T3 (es) Sistemas terapeuticos transdermicos.
NO941593D0 (es)
BR9609794A (pt) Sistema terapêutico transdermal (stt)
EP0387751A3 (en) Medicated plasters
DE59405277D1 (de) Wirkstoffplaster
ES2045470T3 (es) Formulaciones medicinales en aerosol.
ES2082828T3 (es) Pesticida de azol.
DE68915413D1 (de) Anzeigevorrichtung mit aktiver Matrix.
BR9306683A (pt) Adesivo proteináceo curado com aldeído
MY102859A (en) A composition for the control of insects.
ES2152979T3 (es) Sistema terapeutico transdermal que contiene estradiol.
FI953533L (fi) Transdermaalinen terapeuttinen järjestelmä, jossa on galantamiinia vaikuttavana aineena
BR9407238A (pt) Dispositivo implantável de fornecimento de droga
DE68920200D1 (de) Anzeigetafel mit aktiver Matrix.
ATE238778T1 (de) Transdermales therapeutisches system zur abgabe von hormonen
DK0457849T3 (da) Klæbemiddel til elektrotransport
ES2133405T3 (es) Sistema terapeutico percutaneo que contiene como sustancia activa 17-beta-estradiol (anhidro).
ES2156220T3 (es) Preparacion transdermica que contiene un metabolito de loratidina con accion antihistaminica.
DE68917651D1 (de) Aktiv-Matrix-Anzeigevorrichtung.
ES2076330T3 (es) Pelicula para uso agricola.
ES2173453T3 (es) Nuevos dispositivos destinados a la administracion transdermica de trimegestona.
ES2033181B1 (es) Una tableta o capsula de herbicida para su aplicacion en arrozales.
ES2103811T3 (es) Terapia antiviral.
TR199700409T1 (xx) Harici kullan�ma mahsus enflamasyon �nleyici madde.
DE59712215D1 (de) Transdermales therapeutisches system mit einer östriol enthaltenden bisphosphatekombination

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 596903

Country of ref document: ES